Fundraising Fox

Alex Gold

Chief Medical Officer at Mineralys Therapeutics · Chief Medical Officer at Beren

United States

Find your path to Alex

393 people in our graph share verified history with Alex — schools, employers, funds. One of them is your warm intro.

Rebecca JamesunlockedAlex: together at The Wharton School (2008)
Alex: together at Harvard Medical School
×6Alex: together at The Wharton School
×3Alex: together at AstraZeneca

About

Alex Gold is a board-certified cardiologist and internist with more than 20 years of experience in biopharma, spanning clinical development, regulatory affairs, medical affairs, strategy, business development, and commercialization. He has led clinical programs across therapeutic areas including cardiovascular, thrombosis, diabetes, lipids, oncology, and nephrology, contributing to marketed products such as CRESTOR, BRILINTA, ONGLYZA, ANDEXXA, and BEVYXXA, and has managed regulatory filings with the FDA, EMA, and PMDA. He currently serves as a member of the board of directors at Mineralys Therapeutics, Inc., and completed medical training at Harvard and management training at Wharton.

Chief Medical Officer at Mineralys Therapeutics

Intro paths

→

In turn, Alex can intro founders to Mineralys Therapeutics's investors below.

Mineralys Therapeutics's investors · 8

Adams Street PartnersChicago · $150M – $750M checksAndera PartnersParis · since 2022Boulder VenturesBoulder · $1M – $4M checks · since 2022Catalys PacificTokyo · since 2022RA CapitalBoston · since 2022Samsara BioCapitalPalo Alto · since 2022SR One Capital ManagementRedwood City · since 2022Ysios CapitalBarcelona · $5.4M – $21.6M checks · since 2022

Chief Medical Officer at Beren

Intro paths

→

In turn, Alex can intro founders to Beren's investors below.

Beren's investors · 5

Alpha Wave GlobalMiamiEisai Innovation, Inc.San FranciscoNarya CapitalColumbusOctave Ventures LlcHendersonUTokyo Innovation Platform Co. Ltd.Tokyo

Co-founders at Beren

JCJason Camm
Jason CammFounder, President & Chief Executive Officer

Experience

  1. Mineralys Therapeutics, Inc.Member Board of Directorscurrent2024 — present
  2. Beren TherapeuticsChief Medical Officercurrent2023 — present
  3. VarmXIndependent Director, Supervisory Boardcurrent2021 — presentLeiden, South Holland, Netherlands
  4. Stanford University School of MedicineAdjunct Professor of Medicinecurrent2014 — presentStanford, CA
  5. CSLHead Medical Officer - Sanifit2022 — 2023United States
  6. SANIFITChief Medical Officer and President, Sanifit, INC2017 — 2022San Francisco Bay Area
  7. Portola PharmaceuticalsSenior Vice President, Clinical Development and Medical Affairs2013 — 2017San Francisco Bay Area
  8. Reata PharmaceuticalsVice President, Head of Clinical Development2012 — 2013
  9. AstraZenecaExecutive Director, Development Leader - BRILINTA2010 — 2012Wilmington, DE
  10. AstraZenecaExecutive Director, Development Leader - CRESTOR2008 — 2010
  11. AstraZenecaExecutive Director, Clinical Development - Diabetes2007 — 2008Wilmington, DE
  12. AstraZenecaSr. Director, Clinical Development2001 — 2007Wilmington, DE and Gothenburg, Sweden
  13. Harvard Clinical Research InstituteResearch Fellow2000 — 2001Boston, MA
  14. Beth Israel Deaconess Medical CenterFellow in Cardiology1998 — 2001Boston, MA
  15. Beth Israel Deaconess Medical CenterResident in Medicine1995 — 1998Greater Boston Area

Skills & more

StrategyBoard of DirectorsClinical DevelopmentClinical TrialsFDAClinical ResearchDiabetesCardiologyMedical AffairsCross-functional Team LeadershipCommercializationDrug Development
+10 morePharmaceutical IndustryIn-licensingDue DiligenceHealthcare ConsultingChange ManagementJoint VenturesGlobal ManagementBiotechnologyEnd Stage Renal DiseaseKey Opinion Leaders

From Alex's professional profile.

Frequently asked questions

Who is Alex Gold?
Alex Gold is a board-certified cardiologist and internist with more than 20 years of experience in biopharma, spanning clinical development, regulatory affairs, medical affairs, strategy, business development, and commercialization. He has led clinical programs across therapeutic areas including cardiovascular, thrombosis, diabetes, lipids, oncology, and nephrology, contributing to marketed products such as CRESTOR, BRILINTA, ONGLYZA, ANDEXXA, and BEVYXXA, and has managed regulatory filings with the FDA, EMA, and PMDA. He currently serves as a member of the board of directors at Mineralys Therapeutics, Inc., and completed medical training at Harvard and management training at Wharton.
Where does Alex Gold work?
Alex Gold is Chief Medical Officer at Mineralys Therapeutics and Chief Medical Officer at Beren.
Where did Alex Gold go to school?
Alex Gold studied at Harvard Medical School (M.D.); The Wharton School (Essentials of Management).

Same school

Also attended Harvard Medical School283

Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 277 more

Also attended The Wharton School2,000

Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst

+ 1,994 more

Shared employers

Also worked at Beren Therapeutics1

Sean LiuPartner at Founders Fund

Also worked at SANIFIT4

Nico Takano MeierGrowth Investor at Five Elms CapitalJoan PerellóManaging Partner at Ysios CapitalPablo CironiManaging Director at Criteria Bio VenturesDamia TormoPresident, CEO, Treasurer and Founder at Artax Biopharma

Also worked at Reata Pharmaceuticals10

Ashley SwerenOperations / Compliance at Standard CryptoJami TaylorHealthcare Operating Partner at RueOne InvestmentsJack NielsenManaging Partner at Vivo CapitalStephen CurtisManaging Partner at MPM BioImpactSean P. NolanChief Executive Officer and Board Chairman at Taysha Gene TherapiesManmeet SoniExecutive Officer, Director at Summit Therapeutics

+ 4 more

Also worked at AstraZeneca117

Detlev BiniszkiewiczManaging Director at MPM BioImpactBriggs MorrisonEntrepreneur Partner at MPM BioImpactJung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyIliam BarkinoInvestor at IndustrifondenSara JawadInvestor at Industrifonden

+ 111 more